In 2020, the market value of insulin pharmaceutical products in India amounted to approximately 376 million U.S. dollars. Insulin constitutes 65% of the insulin and biosimilars market in India owing to the country's large diabetic population.
Market value of insulin and biosimilars in India in 2020
(in millions U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
EY. (February 22, 2021). Market value of insulin and biosimilars in India in 2020 (in millions U.S. dollars) [Graph]. In Statista. Retrieved December 23, 2024, from https://www.statista.com/statistics/1239139/india-insulin-and-biosimilars-market-value/
EY. "Market value of insulin and biosimilars in India in 2020 (in millions U.S. dollars)." Chart. February 22, 2021. Statista. Accessed December 23, 2024. https://www.statista.com/statistics/1239139/india-insulin-and-biosimilars-market-value/
EY. (2021). Market value of insulin and biosimilars in India in 2020 (in millions U.S. dollars). Statista. Statista Inc.. Accessed: December 23, 2024. https://www.statista.com/statistics/1239139/india-insulin-and-biosimilars-market-value/
EY. "Market Value of Insulin and Biosimilars in India in 2020 (in Millions U.S. Dollars)." Statista, Statista Inc., 22 Feb 2021, https://www.statista.com/statistics/1239139/india-insulin-and-biosimilars-market-value/
EY, Market value of insulin and biosimilars in India in 2020 (in millions U.S. dollars) Statista, https://www.statista.com/statistics/1239139/india-insulin-and-biosimilars-market-value/ (last visited December 23, 2024)
Market value of insulin and biosimilars in India in 2020 (in millions U.S. dollars) [Graph], EY, February 22, 2021. [Online]. Available: https://www.statista.com/statistics/1239139/india-insulin-and-biosimilars-market-value/